MENU
EVGN
AS OF
Dec 24 closing price
Price
$1.05
Change
+$0.01 (+0.96%)
Capitalization
9.1M
70 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
EVGN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Evogene (EVGN) Ownership - Who owns Evogene?

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
13 Gad Feinstein Street
Phone
+972 89311900
Employees
142
Web
https://www.evogene.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
9.1M
P/E Ratio
0.30
Total Cash
15.96M
Projected Growth
N/A
Total Debt
2.52M
Revenue
8.02M
Risk (Beta)
2.40
Dividend Yield
N/A
Total Cash/Share
1.83
Total Debt/Equity
N/A
Revenue/Share
1.08 USD as % of share price

Fundamentals

EVGN
Capitalization
9.1M
P/E Ratio
0.30
Risk (Beta)
2.40
Dividend Yield
N/A
Total Cash
16M
Total Cash/Share
1.83
Total Debt
2.52M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.08%
Revenue
8.02M
ROE
N/A
Book Value
1.14M
P/B Ratio
8.01
Cash Flow
N/A
Earnings
-0.14
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
489K
Current Ratio
5.11
Current Revenue Per Employee
4160.00
Dividends Per Share - Security
N/A
EBITDA
-9.47M
Float
N/A
Float - Current
N/A
Gross Income Margin
49.68
Revenue To Assets
-8.31
Shares Held By Institutions
330K
Shares Outstanding - Current
8.72M
Total Liabilities
8.83M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-43.850
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
EVGN
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. EVGN showed earnings on November 20, 2025. You can read more about the earnings report here.
View AI-Driven Trading for EVGN
A.I. Advisor
published General Information

General Information

a developer of plant traits for the agriculture and biofuel industries

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
13 Gad Feinstein Street
Phone
+972 89311900
Employees
142
Web
https://www.evogene.com